Encouraging Results and Updates in Personalized Neoantigen Targeting Vaccines

NIH Director’s Lecture | Wednesday, January 6, 2027 | 2:00 to 3:00 p.m. ET

Catherine J. Wu, M.D., is a physician-scientist at Dana-Farber Cancer Institute whose research focuses on the biology and treatment of chronic lymphocytic leukemia (CLL). Her laboratory uses genomic, transcriptomic, and immunologic approaches to identify tumor-specific antigens, define CLL driver genes, and understand tumor heterogeneity and treatment response. Dr. Wu has led clinical studies of personalized cancer vaccines and immune-based therapies, including approaches following allogeneic stem cell transplantation. She received her M.D. from Stanford University, trained at Brigham and Women’s Hospital, and completed fellowship training at Dana-Farber/Partners CancerCare, where she leads the Division of Stem Cell Transplantation and Cellular Therapies program.

View the Videocast